Novo Nordisk AS (NVO)
109.94
-2.00
(-1.79%)
USD |
NYSE |
Nov 04, 12:56
Novo Nordisk EPS Diluted (Quarterly): 0.6481 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.6481 |
| March 31, 2024 | 0.8273 |
| December 31, 2023 | 0.7086 |
| September 30, 2023 | 0.7302 |
| June 30, 2023 | 0.6314 |
| March 31, 2023 | 0.6331 |
| December 31, 2022 | 0.4138 |
| September 30, 2022 | 0.4292 |
| June 30, 2022 | 0.4195 |
| March 31, 2022 | 0.4691 |
| December 31, 2021 | 0.3661 |
| September 30, 2021 | 0.4178 |
| June 30, 2021 | 0.4262 |
| March 31, 2021 | 0.4417 |
| December 31, 2020 | 0.3212 |
| September 30, 2020 | 0.3472 |
| June 30, 2020 | 0.3345 |
| March 31, 2020 | 0.3728 |
| December 31, 2019 | 0.2743 |
| September 30, 2019 | 0.3195 |
| June 30, 2019 | 0.3031 |
| March 31, 2019 | 0.3318 |
| December 31, 2018 | 0.2698 |
| September 30, 2018 | 0.2916 |
| June 30, 2018 | 0.3413 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.3629 |
| December 31, 2017 | 0.2658 |
| September 30, 2017 | 0.3129 |
| June 30, 2017 | 0.2965 |
| March 31, 2017 | 0.2908 |
| December 31, 2016 | 0.2509 |
| September 30, 2016 | 0.2901 |
| June 30, 2016 | 0.2976 |
| March 31, 2016 | 0.2743 |
| December 31, 2015 | 0.2376 |
| September 30, 2015 | 0.2427 |
| June 30, 2015 | 0.2391 |
| March 31, 2015 | 0.287 |
| December 31, 2014 | 0.2106 |
| September 30, 2014 | 0.2196 |
| June 30, 2014 | 0.2444 |
| March 31, 2014 | 0.223 |
| December 31, 2013 | 0.2071 |
| September 30, 2013 | 0.2124 |
| June 30, 2013 | 0.2181 |
| March 31, 2013 | 0.1947 |
| December 31, 2012 | 0.1831 |
| September 30, 2012 | 0.1734 |
| June 30, 2012 | 0.167 |
| March 31, 2012 | 0.7335 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.2743
Minimum
Dec 2019
0.8273
Maximum
Mar 2024
0.4848
Average
0.4262
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
| Evaxion Biotech AS | -1.20 |
| Amgen Inc | 5.22 |
| Viking Therapeutics Inc | -0.22 |
| Adaptimmune Therapeutics PLC | 0.24 |
| Genfit SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.894B |
| Revenue (Quarterly) | 9.824B |
| Total Expenses (Quarterly) | 6.081B |
| Enterprise Value | 497.34B |
| Gross Profit Margin (Quarterly) | 84.90% |
| Profit Margin (Quarterly) | 29.46% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 3.29% |
| Normalized Earnings Yield | 2.651 |